These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12627339)
1. [Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac)]. Ludwig C; Brinkmeier T; Frosch PJ Dtsch Med Wochenschr; 2003 Mar; 128(10):487-90. PubMed ID: 12627339 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience. Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320 [TBL] [Abstract][Full Text] [Related]
3. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Friedmann PS; Strickland I; Pirmohamed M; Park BK Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341 [TBL] [Abstract][Full Text] [Related]
4. A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin. Mansur AT; Aydingöz IA Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):100-2. PubMed ID: 15752129 [TBL] [Abstract][Full Text] [Related]
8. Fatal toxic epidermal necrolysis due to lansoprazole. Heaton NR; Edmonds EV; Francis ND; Bunker CB; Bowling JC; Morar N Clin Exp Dermatol; 2004 Nov; 29(6):612-3. PubMed ID: 15550134 [TBL] [Abstract][Full Text] [Related]
9. Toxic epidermal necrolysis and neutropaenia: complications of omeprazole. Thakor AS; Burke A; Handfield-Jones S; Sinha A; Palmer M; Burns A Australas J Dermatol; 2009 Aug; 50(3):207-10. PubMed ID: 19659985 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Schattenkirchner M; Milachowski KA Clin Rheumatol; 2003 May; 22(2):127-35. PubMed ID: 12740678 [TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). Friedman B; Orlet HK; Still JM; Law E South Med J; 2002 Oct; 95(10):1213-4. PubMed ID: 12425513 [TBL] [Abstract][Full Text] [Related]
13. Erythema multiforme and related disorders. Al-Johani KA; Fedele S; Porter SR Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):642-54. PubMed ID: 17344075 [TBL] [Abstract][Full Text] [Related]
14. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction]. Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195 [TBL] [Abstract][Full Text] [Related]
15. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). Nelson C; Rigel D; Smith S; Swanson N; Wolf J J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784 [TBL] [Abstract][Full Text] [Related]
16. [Toxic epidermal necrolysis induced by NSAID]. Spornraft-Ragaller P; Ragaller M; Meurer M Z Rheumatol; 2003 Oct; 62(5):474-5. PubMed ID: 14579035 [No Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis after paroxetine treatment. Ahmed R; Eagleton C N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and etiological aspects of erythema multiforme. A propos of 40 cases]. Maleville J; Massicot P; Ponge A; Guillard JM; Sarrat P; Guillet G Sem Hop; 1983 Mar; 59(10):671-5. PubMed ID: 6304887 [TBL] [Abstract][Full Text] [Related]